Concepedia

Zhenlei Zhang

ZZ

Statistics

Publications

33

Citations

1.1K

H-Index

23

Active since

2016

Affiliations

Guangxi Normal University(Current)

China Pharmaceutical University

Nantong University

Jiangxi Normal University

Ministry of Science and Technology of the People's Republic of China

Zhenlei Zhang is an author at Guangxi Normal University specializing in pharmacology, pharmacy, and drug delivery.

ORCID

Publications per year

2016–2025

33

Publications

33

Designing anticancer copper(II) complexes by optimizing 2-pyridine-thiosemicarbazone ligands

Jungang Deng, Ping Yu, Zhenlei Zhang et al. · European Journal of Medicinal Chemistry · 2018 · 89 citations · Full text

, , +12

Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer

Ming Jiang, Zhenlei Zhang, Wenjuan Li et al. · Journal of Medicinal Chemistry · 2022 · 65 citations

, , +17

Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin

Zhenlei Zhang, Juzheng Zhang, Tongfu Yang et al. · Journal of Medicinal Chemistry · 2023 · 59 citations

, , +17

Designing a Mitochondria-Targeted Theranostic Cyclometalated Iridium(III) Complex: Overcoming Cisplatin Resistance and Inhibiting Tumor Metastasis through Necroptosis and Immune Response

Wenjuan Li, Ting Li, Ying Pan et al. · Journal of Medicinal Chemistry · 2024 · 58 citations

, , +14

Anticancer and biological properties of a Zn-2,6-diacetylpyridine bis(thiosemicarbazone) complex

Ping Yu, Jungang Deng, Jinhua Cai et al. · Metallomics · 2019 · 53 citations

, , +17

1–5 of 33